Prenatal and pre-implantation genetic testing for monogenic disorders for germline cancer susceptibility gene variants: UK joint consensus guidance
- PMID: 37334763
- DOI: 10.1111/1471-0528.17571
Prenatal and pre-implantation genetic testing for monogenic disorders for germline cancer susceptibility gene variants: UK joint consensus guidance
References
REFERENCES
-
- Mandelker D, Donoghue M, Talukdar S, Bandlamudi C, Srinivasan P, Vivek M, et al. Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group. Ann Oncol. 2019;30(8):1221-31.
-
- Reumkens K, Tummers MH, Gietel-Habets JJ, van Kuijk SM, Aalfs CM, van Asperen CJ, et al. The development of an online decision aid to support persons having a genetic predisposition to cancer and their partners during reproductive decision-making: a usability and pilot study. Fam Cancer. 2019;18(1):137-46.
-
- Daar J, Benward J, Collins L, Davis J, Davis O, Francis L, et al. Use of preimplantation genetic testing for monogenic defects (PGT-M) for adult-onset conditions: an Ethics Committee opinion. Fertil Steril. 2018;109(6):989-92.
-
- Wang CW, Hui EC. Ethical, legal and social implications of prenatal and preimplantation genetic testing for cancer susceptibility. Reprod Biomed Online. 2009;19:23-33.
-
- Kulkarni A, Kilby MD. Prenatal diagnosis and pre-implantation genetic diagnosis for cancer susceptibility conditions. BJOG. 2022;129(5):760.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
